Chargement en cours...
Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma
Neuroblastoma is a pediatric cancer of the developing sympathetic nervous system. High-risk neuroblastoma patients typically undergo an initial remission in response to treatment, followed by recurrence of aggressive tumors that have become refractory to further treatment. The need for biomarkers th...
Enregistré dans:
| Publié dans: | Cancer Inform |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6413431/ https://ncbi.nlm.nih.gov/pubmed/30886518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1176935119832910 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|